Originalarbeiten Prof. von Rahden

Wissenschaftliche Arbeiten in Zeitschriften mit Gutachtersystem

  1. Werner YB, Hakanson B, Martinek J, Repici A, von Rahden BHA, Bredenoord AJ, Bisschops R, Messmann H, Vollberg MC, Noder T, Kersten JF, Mann O, Izbicki J, Pazdro A, Fumagalli U, Rosati R, Germer CT, Schijven MP, Emmermann A, von Renteln D, Fockens P, Boeckxstaens G, Rösch T. (2019) Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia. New Engl J Med 381(23):2219-2229.
  2. Choné A, Familiari P, von Rahden BHA, Desai P, Inoue H, Shimamura Y, Eleftheriadis N, Yamashita K, Khashab MA, Shiwaku H, Seewald S, Draganov PV, Alvarez LBM, Chaussade S, Tantau M, Abraham M, Marks J, Arevalo G, Albéniz E, Mion F, Roman S, Rivory J, Dubois R, Lachaux A, Benech N, Subtil F, Ponchon T, Barret M, Pioche M (2019) Multicenter Evaluation of Clinical Efficacy and Safety of Per-oral Endoscopic Myotomy in Children. J Pediatr Gastroenterol Nutr. 69:523-527.
  3. Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, von Rahden BHA, Desai PN, Pioche M, Hayee B, Haji A, Saxena P, Reavis K, Onimaru M, Balassone V, Nakamura J, Hata Y, Yang D, Pannu D, Abbas A, Perbtani YB, Patel LY, Filser J, Roman S, Rivory J, Mion F, Ponchon T, Perretta S, Wong V, Maselli R, Ngamruengphong S, Chen YI, Bukhari M, Hajiyeva G, Ismail A, Pieratti R, Kumbhari V, Galdos-Cardenas G, Repici A, Khashab MA (2017) Comprehensive Analysis of Adverse Events Associated With Per Oral Endoscopic Myotomy in 1826 Patients: An International Multicenter Study. Am J Gastroenterol 112:1267-1276. doi: 10.1038/ajg.2017.139.
  4. Lichthardt S, Kerscher A, Dietz UA, Jurowich C, Kunzmann V, von Rahden BHA, Germer CT, Wiegering A. (2016) Role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer. BMC Cancer 16:650. doi: 10.1186/s12885-016-2708-0.
  5. Becker J, Niebisch S, Ricchiuto A, Schaich EJ, Lehmann G, Waltgenbach T, Schafft A, Hess T, Lenze F, Venerito M, Hüneburg R, Lingohr P, Matthaei H, Seewald S, Scheuermann U, Kreuser N, Veits L, Wouters MM, Gockel HR, Lang H, Vieth M, Müller M, Eckardt AJ, von Rahden BHA, Knapp M, Boeckxstaens GE, Fimmers R, Nöthen MM, Schulz HG, Gockel I, Schumacher J. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia. Eur J Gastroenterol Hepatol. 2016 Jun;28(6):689-95. doi: 10.1097/MEG.0000000000000602.
  6. Becker J, Haas SL, Mokrowiecka A, Wasielica-Berger J, Ateeb Z, Bister J, Elbe P, Kowalski M, Gawron-Kiszka M, Majewski M, Mulak A, Janiak M, Wouters MM, Schwämmle T, Hess T, Veits L, Niebisch S, Santiago JL, de León AR, de la Serna JP, Urcelay E, Annese V, Latiano A, Fumagalli U, Rosati R, Laghi L, Cuomo R, Lenze F, Sarnelli G, Müller M, von Rahden BHA, Wijmenga C, Lang H, Czene K, Hall P, de Bakker PI, Vieth M, Nöthen MM, Schulz HG, Adrych K, Gąsiorowska A, Paradowski L, Wallner G, Boeckxstaens GE, Gockel I, Hartleb M, Kostic S, Dziurkowska-Marek A, Lindblad M, Nilsson M, Knapp M, Thorell A, Marek T, Dąbrowski A, Małecka-Panas E, Schumacher J. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur J Hum Genet. 2016 Aug;24(8):1228-31. doi: 10.1038/ejhg.2015.262.
  7. Ngamruengphong S, von Rahden BHA, Filser J, Tyberg A, Desai A, Sharaiha RZ, Lambroza A, Kumbhari V, El Zein M, Abdelgelil A, Besharati S, Clarke JO, Stein EM, Kalloo AN, Kahaleh M, Khashab MA. Intraoperative measurement of esophagogastric junction cross-sectional area by impedance planimetry correlates with clinical outcomes of peroral endoscopic myotomy for achalasia: a multicenter study. Surg Endosc. 2016 Jul;30(7):2886-94. doi: 10.1007/s00464-015-4574-2.
  8. Seyfried F, von Rahden BHA, Miras AD, Gasser M, Maeder U, Kunzmann V, Germer CT, Pelz J, Kerscher AG. Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin–a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer. 2015 Feb 19;15:73. doi: 10.1186/s12885-015-1081-8.
  9. Gockel I, Becker J, Wouters MM, Niebisch S, Gockel HR, Hess T, Ramonet D, Zimmermann J, Vigo AG, Trynka G, de León AR, de la Serna JP, Urcelay E, Kumar V, Franke L, Westra HJ, Drescher D, Kneist W, Marquardt JU, Galle PR, Mattheisen M, Annese V, Latiano A, Fumagalli U, Laghi L, Cuomo R, Sarnelli G, Müller M, Eckardt AJ, Tack J, Hoffmann P, Herms S, Mangold E, Heilmann S, Kiesslich R, von Rahden BHA, Allescher HD, Schulz HG, Wijmenga C, Heneka MT, Lang H, Hopfner KP, Nöthen MM, Boeckxstaens GE, de Bakker PI, Knapp M, Schumacher J (2014) Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet 46:901-904. doi: 10.1038/ng.3029.
  10. Hensel F, Timmermann W, von Rahden BHA, Rosenwald A, Brändlein S, Illert B (2014) Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1. Oncol Rep 31:1059-1066. doi: 10.3892/or.2014.2987.
  11. von Rahden BHA, Kircher S, Landmann D, Schlegel N, Lazariotou M, Jurowich CF, Germer CT, Grimm M (2012) Glucocorticoid-induced tumour necrosis factor receptor expression: a potential molecular link between steroid intake and complicated diverticulitis? Colorectal Dis 14:1276-86. doi: 10.1111/j.1463-1318.2012.02967.x
  12. von Rahden BHA, Spor L, Germer CT, Dietz UA (2012) Three-component intraperitoneal mesh fixation for laparoscopic repair of anterior parasternal costodiaphragmatic hernias. J Am Coll Surg 214:e1-6. doi: 10.1016/j.jamcollsurg.2011.10.001.
  13. von Rahden BHA, Jurowich C, Kircher S, Lazariotou M, Jung M, Germer CT, Grimm M (2012) Allergic predisposition, histamine and histamine receptor expression (H1R, H2R) are associated with complicated courses of sigmoid diverticulitis. J Gastrointest Surg. 16:173-182; discussion 182. doi: 10.1007/s11605-011-1702-8.
  14. Jurowich CF, Jellouschek S, Adamus R, Loose R, Kaiser A, Isbert C, Germer CT, von Rahden BHA (2011) How complicated is complicated diverticulitis?–phlegmonous diverticulitis revisited. Int J Colorectal Dis 26:1609-17. doi: 10.1007/s00384-011-1280-y.
  15. Grimm M, Lazariotou M, Kircher S, Höfelmayr A, Germer CT, von Rahden BHA, Waaga-Gasser AM, Gasser M (2011) Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment. Cell Oncol (Dordr). 34:315-326. doi: 10.1007/s13402-011-0027-7.
  16. von Rahden BHA, Kircher S, Thiery S, Landmann D, Jurowich CF, Germer CT, Grimm M (2011) Association of steroid use with complicated sigmoid diverticulitis: potential role of activated CD68+/CD163+ macrophages. Langenbecks Arch Surg 396:759-768. doi: 10.1007/s00423-011-0797-4.
  17. Kim M, Reibetanz J, Steinkirchner S, von Rahden BHA, Germer CT, Jurowich CF (2011) [Quality of life after fast track colorectal surgery]. Dtsch Med Wochenschr 136:997-1002. doi: 10.1055/s-0031-1275833.
  18. Kim M, Reibetanz J, Steinkirchner S, von Rahden BHA, Germer CT, Jurowich CF (2011) Lebensqualität nach Kolonchirurgie unter „Fast Track”-Bedingungen. Dtsch Med Wochenschr 136:997-1002. doi: 10.1055/s-0031-1275833.
  19. von Rahden BHA, Kircher S, Kafka M, Stuermer L, Reiber C, Gattenlöhner S, Germer CT, Grimm M. Glucocorticoid-induced TNFR family-related Receptor (GITR)-expression in Tumor Infiltrating Leucocytes (TILs) is associated with the pathogenesis of Esophageal Adenocarcinomas with and without Barrett´s mucosa Cancer Biomark 7:285-94.
  20. von Rahden BHA, Kircher S, Lazariotou M, Reiber C, Stuermer L, Otto C, Germer CT, Grimm M (2011) LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett’s esophagus? J Exp Clin Cancer Res 30:23. doi: 10.1186/1756-9966-30-23.
  21. Grimm M, Lazariotou M, Kircher S, Stuermer L, Reiber C, Hofelmayr A, Gattenlohner S, Otto C, Germer CT, von Rahden BHA (2010) MMP-1 is a (pre-) invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med. 8: 99.
  22. Grimm M, Lazariotou M, Kircher S, Höfelmayr A, Germer CT, von Rahden BHA, Waaga-Gasser AM, Gasser M (2010) Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer – indications for anti-TNF-α agents in cancer treatment. Anal Cell Pathol 33:151-163.
  23. Grimm M, Kim M, Rosenwald A, von Rahden BHA, Tsaur I, Meier E, Heemann U, Germer CT, Gasser M, Waaga-Gasser AM (2010) Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. Eur J Cancer 46:2314-2323.
  24. Jurowich CF, Reibetanz J, Krajinovic K, Larena-Avellaneda A, Isbert C, Oberender P, Germer CT, von Rahden BHA (2019) Kostenanalyse des Fast Track Konzeptes bei elektiver Kolonchirurgie. / [Cost Analysis of the Fast Track Concept in Elective Colonic Surgery.] Zentralbl Chir 136:256-63.
  25. Witzel K, von Rahden BHA, Stein HJ (2009) The effect of ultrasound dissection in thyroid surgery. Eur Surg Res 43: 241-4.
  26. von Rahden BHA, Stein HJ, Weber A, Vieth M, Stolte M, Rösch T, Schmid RM, Sarbia M, Meining A (2008) Critical Reappraisal of Current Surveillance Strategies for Barrett’s Oesophagus: Analysis of a large German Barrett’s Database. Dis Esophagus 21: 685-9.
  27. von Rahden BHA, Stein HJ, Hartl S, Theisen J, Stigler B, Siewert JR, Sarbia M (2008) Expression of Prastaglandin Synthase E in Esophageal Adenocarcinomas. Dis Esophagus 21: 304-308.
  28. Witzel K, von Rahden BHA, Kaminski C, Stein HJ (2008) The transoral access in endoscopic thyroid resection. Surg Endosc 22: 1871-1875.
  29. Gmeiner D, von Rahden BHA, Hutter J, Stein HJ (2007) Flexible versus Rigid Endoscopy for Treatment of Foreign Body Ingestion: Proposal of a Therapeutic Algorithm. Surg Endosc 21: 2026-2029.
  30. von Rahden BHA, Brücher BLDM, Langner C, Hartl SA, Theisen J, Siewert JR, Stein HJ, Sarbia M (2006) Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinomas of the small intestine. Br J Surg 93:1424-1432.
  31. von Rahden BHA, Stein HJ, Pühringer-Oppermann F, Sarbia M (2006) C-myc-Amplification is Frequent in Barrett’s Cancer and Linked with Angiogenesis by Correlation with VEGF-A Expression. Neoplasia 8: 702-707.
  32. von Rahden BHA, Stein HJ, Feith M, Theisen J, Siewert JR, Sarbia M (2006) Overexpression of TGF-Beta-1 in Barrett’s Cancer is Associated with Advanced Stage of Disease and A Worse Prognosis. Mol Carcinogen 45: 786-794.
  33. Langer R, von Rahden BHA, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Hofler H, Sarbia M (2006) Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol 59: 631-634.
  34. von Rahden BHA, Langner C, Brücher BLDM, Stein HJ, Sarbia M (2006) No association of Primary Adenocarcinomas of the Small Intestine with Epstein-Barr Virus Infection. Mol Carcinogen 45:349-352.
  35. von Rahden BHA, Sarbia M, Stein HJ (2006) Combined FDG-PET/ CT and CT-guided biopsy for Diagnosing Esophageal Cancer Recurrence. N Z Med J 2006; 119: U1810.
  36. von Rahden BHA, Brucher BL, Sarbia M (2006) Esophageal squamous cell carcinoma with entirely intramural growth pattern. Virchows Arch 448: 862-866.
  37. Stigler B, von Rahden BHA, Weiss W, Stein HJ (2006) Interventional radiology for management of celiac trunk bleeding after pancreatic surgery. J Am Coll Surg 202: 1018-1019.
  38. von Rahden BHA, Feith M, Stein HJ (2006) Limitierte chirurgische Resektion versus lokale endoskopische Therapie beim Frühkarzinom des ösophagogastralen Übergangs. [Limited resection versus local endoscopic therapy of early cancers of the esophagogastric junction.] Zentralbl Chir 2006; 131: 97-104.
  39. von Rahden BHA, Stein HJ, Scherer M (2005) Late Hypopharyngo-Esophageal Perforation after Cervical Spine Surgery: Proposal of a Therapeutic Strategy. Eur Spine J 14: 880-886.
  40. Sarbia M, zur Hausen A, Feith M, Geddert H, von Rahden BHA, Langer R, von Weyhern C, Siewert JR, Höfler H, Stein HJ (2005) Esophageal (Barrett’s) adenocarcinoma is not associated with Epstein-Barr Virus infection – an analysis of 162 cases. Int J Cancer 117: 698-700.
  41. von Rahden BHA, Stein HJ, Pühringer F, Langer R, Koch I, Siewert JR, Höfler H, Sarbia M (2005) Coexpression of Cyclooxygenases (COX-1, COX-2) and Vascular Endothelial Growth Factors (VEGF-A, VEGF-C) in Esophageal Adenocarcinoma. Cancer Res 65: 5038-5044.
  42. von Rahden BHA, Stein HJ, Feith M, Becker K, Siewert JR (2005) Lymphatic Vessel Invasion as Prognostic Factor in Patients with Primary Resected Adenocarcinomas of the Esophagogastric Junction. J Clin Oncol 23: 874-879.
  43. von Rahden BHA, Stein HJ, Langer R, Schenk E, von Weyhern CW, Döring C, Siewert JR, Höfler H, Sarbia M (2005) The C609T polymorphism in the NAD(P)H:Quinone Oxidoreductase I has no major impact on carcinogenesis of adenocarcinoma of the distal esophagus. Int J Cancer 113: 506-508.
  44. von Rahden BHA, Stein HJ, Becker K, Siewert JR (2005) Esophageal Adenocarcinomas in Heterotopic Gastric Mucosa: Review and Report of a Case with Complete Response to Neoadjuvant Radiochemotherapy. Digest Surg 22: 107-112.
  45. von Rahden BHA, Stein HJ, Schmidt G, Bartels H, Overbeck M, Siewert JR (2005) Esophageal Cancer Surgery in Heart Transplant Patients. Ann Thoracic Surg 80: 1510-1512.
  46. Stein HJ, von Rahden BHA, Siewert JR (2004) Survival after Surgery of Cancer of the Esophagus. Langenbecks Arch Surg 2004; 390: 280-285.
  47. Pross M, von Rahden BHA, Schubert D, Feussner H (2004) Rendezvousverfahren im Bereich des Ösophagus. Chir Gastroenterol 20:100-4.
  48. von Rahden BHA, Stein HJ, Feussner H, Siewert JR (2004) Enucleation of Submucosal Tumors of the Esophagus: Minimally-Invasive Versus Open Approach. Surg Endosc 18:924-30.
  49. von Rahden BHA, Stein HJ, Becker K, Liebermann Meffert D, Siewert JR (2004) Heterotopic Gastric Mucosa of the Esophagus. Literature-Review and Proposal of a Clinicopathologic Classification. Am J Gastroenterol 99: 543-551.
  50. von Rahden BHA, Becker I, Stein HJ (2004) Esophageal Perforation by Portions of a Wild Boar. Zentralbl Chir 129: 1-3.
  51. von Rahden BHA, Stein HJ, Becker I, Reiter R (2003) Delayed aortic rupture after radiochemotherapy and esophagectomy for esophageal cancer. Dis Esophagus 16: 346-349.
  52. von Rahden BHA, Feith M, Dittler HJ, Stein HJ (2002) Cervical esophageal perforation with severe mediastinitis due to an impacted dental prosthesis. Dis Esophagus 15: 340-344.
  53. Aumüller G, Leonhardt M, Renneberg H, von Rahden BHA, Bjartell A, Abrahamsson PA (2001) Semiquantitative Morphology of Human Prostatic Development and Regional Distribution of Prostatic Neuroendocrine Cells. Prostate 46: 108-115.
  54. Aumüller G, Holterhus P-M, Konrad L, von Rahden BHA, Hiort O, Esquenet M and Verhoeven G (1998) Immunohistochemistry and in situ hybridization of the androgen receptor in the developing human prostate. Anat Embryol 197: 199-208.

Zu den Übersichtsarbeiten und Kommentaren